Sahar Gholamian

ORCID: 0009-0003-7781-5064 · 1 paper in corpus

article 2026

In silico evaluation of procyanidin as a potential ESR1 inhibitor: docking and MD insights in uterine fibroids and endometriosis

In silico pharmacology ·doi:10.1007/s40203-025-00541-z

These are two of the most common gynecologic diseases, affecting 15% to 80% of women of childbearing age diseases. The existing treatments, such as hormonal drugs and selective estrogen receptor modulators like raloxifene, have side effects…